Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
Melike Melikoğlu(Istanbul University-Cerrahpaşa), Hasan Yazıcı(Istanbul University), Sebahattin Yurdakul(Istanbul University), Vedat Hamuryudan(Istanbul University), İzzet Fresko(Access to Wholistic and Productive Living Institute), Cem Mat(Access to Wholistic and Productive Living Institute), Yılmaz Özyazgan(Istanbul University-Cerrahpaşa), Feride Göğüş
PubMed
January 1, 2005
Cited by 293
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
The Long-Term Mortality and Morbidity of Behçet Syndrome
|Medicine|2003|757
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
A Controlled Trial of Azathioprine in Behçet's Syndrome
|New England Journal of Medicine|1990|646
Behçet syndrome: a contemporary view
|Nature Reviews Rheumatology|2018|438